Across TCGA pan-cancer cohorts, FLVCR1-DT RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated FLVCR1-DT data layer.
The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher FLVCR1-DT RNA is associated with better overall survival. In most high-consensus cancer types, elevated FLVCR1-DT expression acts as an unfavorable survival marker, although some lineages such as PAAD and OV show a favorable association.
PAAD, ACC, and OV are the cancer types where FLVCR1-DT RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.